Comments
Loading...

Docebo Analyst Ratings

DCBONASDAQ
Logo brought to you by Benzinga Data
$31.24
0.321.03%
At close: -
$31.24
0.000.00%
After Hours: 4:00 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$62.00
Lowest Price Target1
$44.00
Consensus Price Target1
$53.25

Docebo Analyst Ratings and Price Targets | NASDAQ:DCBO | Benzinga

Docebo Inc has a consensus price target of $53.25 based on the ratings of 8 analysts. The high is $62 issued by Craig-Hallum on November 11, 2024. The low is $44 issued by CIBC on June 21, 2024. The 3 most-recent analyst ratings were released by Scotiabank, Craig-Hallum, and Needham on March 4, 2025, November 11, 2024, and November 8, 2024, respectively. With an average price target of $55.67 between Scotiabank, Craig-Hallum, and Needham, there's an implied 78.19% upside for Docebo Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Oct 24
2
Nov 24
0
0
0
0
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Scotiabank
Craig-Hallum
Needham
CIBC
Canaccord Genuity

1calculated from analyst ratings

Analyst Ratings for Docebo

Buy NowGet Alert
03/04/2025Buy Now44.05%Scotiabank
Kevin Krishnaratne35%
$55 → $45MaintainsSector OutperformGet Alert
11/11/2024Buy Now98.46%Craig-Hallum
George Sutton66%
$58 → $62MaintainsBuyGet Alert
11/08/2024Buy Now92.06%Needham
Ryan MacDonald58%
$50 → $60MaintainsBuyGet Alert
10/24/2024Buy Now76.06%Scotiabank
Kevin Krishnaratne35%
$50 → $55MaintainsSector OutperformGet Alert
09/12/2024Buy Now60.05%Needham
Ryan MacDonald58%
$45 → $50MaintainsBuyGet Alert
06/21/2024Buy Now40.85%CIBC
Stephanie Price48%
$53 → $44MaintainsOutperformerGet Alert
06/12/2024Buy Now44.05%Needham
Ryan MacDonald58%
$45 → $45ReiteratesBuy → BuyGet Alert
06/07/2024Buy Now85.66%Craig-Hallum
George Sutton66%
→ $58Initiates → BuyGet Alert
05/16/2024Buy Now44.05%Needham
Ryan MacDonald58%
$45 → $45ReiteratesBuy → BuyGet Alert
05/14/2024Buy Now76.06%Canaccord Genuity
Robert Young35%
$65 → $55MaintainsBuyGet Alert
05/14/2024Buy Now60.05%Scotiabank
Kevin Krishnaratne35%
$65 → $50MaintainsSector OutperformGet Alert
05/13/2024Buy Now69.65%CIBC
Stephanie Price48%
$58 → $53MaintainsOutperformerGet Alert
05/13/2024Buy Now88.86%Morgan Stanley
Josh Baer62%
$65 → $59MaintainsOverweightGet Alert
05/13/2024Buy Now53.65%Goldman Sachs
Kevin Kumar53%
$55 → $48MaintainsNeutralGet Alert
05/13/2024Buy Now44.05%Needham
Ryan MacDonald58%
$63 → $45MaintainsBuyGet Alert
04/19/2024Buy Now108.07%Morgan Stanley
Josh Baer62%
$67 → $65MaintainsOverweightGet Alert
02/26/2024Buy Now76.06%Goldman Sachs
Kevin Kumar53%
$44 → $55MaintainsNeutralGet Alert
02/26/2024Buy Now108.07%Scotiabank
Kevin Krishnaratne35%
$60 → $65MaintainsSector OutperformGet Alert
02/26/2024Buy Now114.47%Morgan Stanley
Josh Baer62%
$63 → $67MaintainsOverweightGet Alert
11/14/2023Buy Now79.26%Needham
Ryan MacDonald58%
→ $56Initiates → BuyGet Alert
11/10/2023Buy Now40.85%Goldman Sachs
Kevin Kumar53%
$39 → $44MaintainsNeutralGet Alert
11/10/2023Buy Now69.65%Morgan Stanley
Josh Jennings61%
$49 → $53MaintainsOverweightGet Alert
08/18/2023Buy Now56.85%Morgan Stanley
Josh Jennings61%
$40 → $49UpgradeEqual-Weight → OverweightGet Alert
08/11/2023Buy Now28.04%Morgan Stanley
Josh Jennings61%
$37 → $40MaintainsEqual-WeightGet Alert
05/22/2023Buy Now18.44%Goldman Sachs
Kevin Kumar53%
→ $37Initiates → NeutralGet Alert
05/12/2023Buy Now18.44%Morgan Stanley
Josh Jennings61%
$39 → $37MaintainsEqual-WeightGet Alert
03/10/2023Buy Now24.84%Morgan Stanley
Josh Jennings61%
$36 → $39MaintainsEqual-WeightGet Alert
03/10/2023Buy Now60.05%Canaccord Genuity
Robert Young35%
$40 → $50MaintainsBuyGet Alert
11/11/2022Buy Now15.24%Morgan Stanley
Josh Baer62%
$40 → $36MaintainsEqual-WeightGet Alert
10/25/2022Buy Now28.04%Morgan Stanley
Josh Baer62%
$44 → $40MaintainsEqual-WeightGet Alert
08/12/2022Buy Now40.85%Morgan Stanley
Josh Baer62%
$41 → $44MaintainsEqual-WeightGet Alert
07/19/2022Buy Now31.24%Morgan Stanley
Josh Baer62%
$43 → $41MaintainsEqual-WeightGet Alert
05/13/2022Buy Now37.64%Morgan Stanley
Josh Baer62%
$54 → $43MaintainsEqual-WeightGet Alert
04/26/2022Buy Now72.86%Morgan Stanley
Josh Baer62%
→ $54Initiates → Equal-WeightGet Alert

FAQ

Q

What is the target price for Docebo (DCBO) stock?

A

The latest price target for Docebo (NASDAQ:DCBO) was reported by Scotiabank on March 4, 2025. The analyst firm set a price target for $45.00 expecting DCBO to rise to within 12 months (a possible 44.05% upside). 16 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Docebo (DCBO)?

A

The latest analyst rating for Docebo (NASDAQ:DCBO) was provided by Scotiabank, and Docebo maintained their sector outperform rating.

Q

When was the last upgrade for Docebo (DCBO)?

A

The last upgrade for Docebo Inc happened on August 18, 2023 when Morgan Stanley raised their price target to $49. Morgan Stanley previously had an equal-weight for Docebo Inc.

Q

When was the last downgrade for Docebo (DCBO)?

A

There is no last downgrade for Docebo.

Q

When is the next analyst rating going to be posted or updated for Docebo (DCBO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Docebo, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Docebo was filed on March 4, 2025 so you should expect the next rating to be made available sometime around March 4, 2026.

Q

Is the Analyst Rating Docebo (DCBO) correct?

A

While ratings are subjective and will change, the latest Docebo (DCBO) rating was a maintained with a price target of $55.00 to $45.00. The current price Docebo (DCBO) is trading at is $31.24, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.